| Name | N-[1-[(2R,3R,5S)-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide | 
|---|---|
| Synonyms | 
                                
                                N-Benzoyl-3'-deoxycytidine
                                
                                
                                 N4-benzoyl-3'-deoxycytidine N4-benzoyl-3'-deoxyribicytidine  | 
                        
| Description | N4-Benzoyl-3’-deoxycytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | 
|---|---|
| Related Catalog | |
| References | 
| Density | 1.503 g/cm3 | 
|---|---|
| Molecular Formula | C16H17N3O5 | 
| Molecular Weight | 331.32 | 
| Exact Mass | 331.11700 | 
| PSA | 113.68000 | 
| LogP | 0.20930 | 
| Precursor 9 | |
|---|---|
| DownStream 2 | |